Find a Trial
Trial Results
7 protocol(s) meet the specified criteria
20170543OPEN TO ACCRUAL
A Phase 1/2, Open-label Study Evaluating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of AMG 510 Monotherapy in Subjects With Advanced Solid Tumors With KRAS p.G12C Mutation and AMG 510 Combination Therapy in Subjects With Advanced NSCLC With KRAS p.G12C Mutation (CodeBreak 100).
A021502OPEN TO ACCRUAL
RANDOMIZED TRIAL OF STANDARD CHEMOTHERAPY ALONE OR COMBINED WITH ATEZOLIZUMAB AS ADJUVANT THERAPY FOR PATIENTS WITH STAGE III COLON CANCER AND DEFICIENT DNA MISMATCH REPAIR
GI-CELLMAX-PRO00100OPEN TO ACCRUAL
Sample Collection Study for the CellMax Life Circulating Tumor Cell and Circulating Tumor DNA Platforms for the Early Detection of Colorectal Cancer and Adenomas
GI-CREATICS-CRTX1-201OPEN TO ACCRUAL
Prospective Collection of Colon Lavage Fluids for Pancreatic Cancer Marker Validation
INTM-CC-IUSCC-0702OPEN TO ACCRUAL
Survivorship Plan HEalth REcord (SPHERE) Implementation Trial.
INTM-IIR-WAMOOPEN TO ACCRUAL
Helping Patients and Providers Make Better Decisions about Colorectal Cancer Screening
IUSCC-0659OPEN TO ACCRUAL
Assessing tobacco use and cessation support among patients with non-tobacco related cancers